These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9298404)

  • 1. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies.
    Ensslin AS; Huber R; Pethran A; Römmelt H; Schierl R; Kulka U; Fruhmann G
    Int Arch Occup Environ Health; 1997; 70(3):205-8. PubMed ID: 9298404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs.
    Ensslin AS; Stoll Y; Pethran A; Pfaller A; Römmelt H; Fruhmann G
    Occup Environ Med; 1994 Apr; 51(4):229-33. PubMed ID: 8199663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs.
    Pilger A; Köhler I; Stettner H; Mader RM; Rizovski B; Terkola R; Diem E; Franz-Hainzl E; Konnaris C; Valic E; Rüdiger HW
    Int Arch Occup Environ Health; 2000 Sep; 73(7):442-8. PubMed ID: 11057412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs.
    Ensslin AS; Pethran A; Schierl R; Fruhmann G
    Int Arch Occup Environ Health; 1994; 65(5):339-42. PubMed ID: 8175190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations.
    Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):5-10. PubMed ID: 12592576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs.
    Mahmoodi M; Soleyman-Jahi S; Zendehdel K; Mozdarani H; Azimi C; Farzanfar F; Safari Z; Mohagheghi MA; Khaleghian M; Divsalar K; Asgari E; Rezaei N
    Drug Chem Toxicol; 2017 Apr; 40(2):235-240. PubMed ID: 27461518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs--evaluation by the micronucleus assay.
    Hessel H; Radon K; Pethran A; Maisch B; Gröbmair S; Sautter I; Fruhmann G
    Mutat Res; 2001 Oct; 497(1-2):101-9. PubMed ID: 11525912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome and SCE analysis in peripheral lymphocytes of persons occupationally exposed to cytostatic drugs handled with and without use of safety covers.
    Oestreicher U; Stephan G; Glatzel M
    Mutat Res; 1990 Dec; 242(4):271-7. PubMed ID: 2255321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide.
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Draicchio F; Apostoli P
    Rapid Commun Mass Spectrom; 1998; 12(20):1485-93. PubMed ID: 9796535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.
    Sessink PJ; Bos RP
    Drug Saf; 1999 Apr; 20(4):347-59. PubMed ID: 10230582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of contamination with antineoplastic agents in a hospital pharmacy department.
    Sessink PJ; Anzion RB; Van den Broek PH; Bos RP
    Pharm Weekbl Sci; 1992 Feb; 14(1):16-22. PubMed ID: 1553250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs].
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Frigerio F; Draicchio F; Apostoli P
    G Ital Med Lav Ergon; 1999; 21(2):93-107. PubMed ID: 10771723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
    Turci R; Sottani C; Ronchi A; Minoia C
    Toxicol Lett; 2002 Aug; 134(1-3):57-64. PubMed ID: 12191861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach.
    Moretti M; Grollino MG; Pavanello S; Bonfiglioli R; Villarini M; Appolloni M; Carrieri M; Sabatini L; Dominici L; Stronati L; Mastrangelo G; Barbieri A; Fatigoni C; Bartolucci GB; Ceretti E; Mussi F; Monarca S
    Int Arch Occup Environ Health; 2015 Aug; 88(6):683-95. PubMed ID: 25362515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
    Poupeau C; Tanguay C; Plante C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2017 Jul; 23(5):323-332. PubMed ID: 27084515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of antineoplastic agents in pharmacy personnel. Part II: study of work-related risk factors.
    Schreiber C; Radon K; Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):11-6. PubMed ID: 12592577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption.
    Venitt S; Crofton-Sleigh C; Hunt J; Speechley V; Briggs K
    Lancet; 1984 Jan; 1(8368):74-7. PubMed ID: 6140425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.